We are live on ! Find out more
MCM

Manchester Capital Management Portfolio holdings

AUM $694M
1-Year Est. Return 22.34%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+22.34%
3 Year Est. Return
+57.67%
5 Year Est. Return
+66.95%
10 Year Est. Return
+238.55%
AUM
$746M
AUM Growth
+$71.2M
Cap. Flow
+$3.95M
Cap. Flow %
0.53%
Top 10 Hldgs %
48.25%
Holding
1,108
New
97
Increased
407
Reduced
172
Closed
107

Sector Composition

Rank Sector Weight
1 Industrials 15.68%
2 Technology 13.13%
3 Financials 7.32%
4 Consumer Discretionary 5.96%
5 Healthcare 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYRG icon
1051
MYR Group
MYRG
$5.25B
-40
Closed -$5.39K
NBIX icon
1052
Neurocrine Biosciences
NBIX
$16.6B
-3
Closed -$338
NTLA icon
1053
Intellia Therapeutics
NTLA
$1.67B
-2,000
Closed -$63.2K
NVCR icon
1054
NovoCure
NVCR
$1.91B
-5
Closed -$81
ADAM
1055
Adamas Trust
ADAM
$883M
-128
Closed -$1.09K
ODP
1056
DELISTED
ODP
ODP
-3
Closed -$139
OM icon
1057
Outset Medical
OM
$90.8M
-1
Closed -$131
OMCL icon
1058
Omnicell
OMCL
$1.68B
-62
Closed -$2.79K
OPCH icon
1059
Option Care Health
OPCH
$3.56B
-76
Closed -$2.46K
OSPN icon
1060
OneSpan
OSPN
$618M
-79
Closed -$850
PBH icon
1061
Prestige Consumer Healthcare
PBH
$2.6B
-17
Closed -$973
PCVX icon
1062
Vaxcyte
PCVX
$8.64B
-1,500
Closed -$76.5K
PGNY icon
1063
Progyny
PGNY
$2.2B
-91
Closed -$3.1K
PHR icon
1064
Phreesia
PHR
$773M
-78
Closed -$1.46K
PII icon
1065
Polaris
PII
$4.07B
-3
Closed -$313
PLMR icon
1066
Palomar
PLMR
$3.45B
-8
Closed -$406
PRCT icon
1067
Procept Biorobotics
PRCT
$1.17B
-60
Closed -$1.97K
PRGS icon
1068
Progress Software
PRGS
$1.76B
-43
Closed -$2.26K
PSMT icon
1069
Pricesmart
PSMT
$5.46B
-9
Closed -$670
RXT icon
1070
Rackspace Technology
RXT
$1.24B
-215
Closed -$506
SGRY icon
1071
Surgery Partners
SGRY
$2.03B
-10
Closed -$293
SHAK icon
1072
Shake Shack
SHAK
$2.87B
-13
Closed -$755
SHOO icon
1073
Steven Madden
SHOO
$3.55B
-32
Closed -$1.02K
SLAB icon
1074
Silicon Laboratories
SLAB
$7.23B
-20
Closed -$2.32K
SLDB icon
1075
Solid Biosciences
SLDB
$900M
-1,000
Closed -$2.52K

Similar funds

Manchester Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Manchester Capital Management held 1,108 positions worth $746M, up 11% from $675M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Manchester Capital Management's Q4 2023 filing shows 97 new, 407 increased, 172 reduced and 107 closed positions. Its largest new stake was Core & Main: 10,180 shares worth $411K. The largest sale was Vanguard S&P 500 ETF, an estimated $4.14M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Manchester Capital Management's largest Q4 2023 buy was Core & Main: 10,180 shares worth $411K.
  • Manchester Capital Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $7M increase.
  • Manchester Capital Management's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.14M.
  • Manchester Capital Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $425K.
  • Manchester Capital Management's ten largest holdings make up 48% of its $746M portfolio in Q4 2023.
  • Manchester Capital Management opened 97 new positions and closed 107 in Q4 2023.
  • Manchester Capital Management's portfolio value rose 11% quarter-over-quarter to $746M.

Based on Manchester Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.